UNLABELLED: This study evaluates the quantitative biodistribution of commercially available CdSe quantum dots (QD) in mice. METHODS: (64)Cu-Labeled 800- or 525-nm emission wavelength QD (21- or 12-nm diameter), with or without 2,000 MW (molecular weight) polyethylene glycol (PEG), were injected intravenously into mice (5.55 MBq/25 pmol QD) and studied using well counting or by serial microPET and region-of-interest analysis. RESULTS: Both methods show rapid uptake by the liver (27.4-38.9 %ID/g) (%ID/g is percentage injected dose per gram tissue) and spleen (8.0-12.4 %ID/g). Size has no influence on biodistribution within the range tested here. Pegylated QD have slightly slower uptake into liver and spleen (6 vs. 2 min) and show additional low-level bone uptake (6.5-6.9 %ID/g). No evidence of clearance from these organs was observed. CONCLUSION: Rapid reticuloendothelial system clearance of QD will require modification of QD for optimal utility in imaging living subjects. Formal quantitative biodistribution/imaging studies will be helpful in studying many types of nanoparticles, including quantum dots.
UNLABELLED: This study evaluates the quantitative biodistribution of commercially available CdSe quantum dots (QD) in mice. METHODS: (64)Cu-Labeled 800- or 525-nm emission wavelength QD (21- or 12-nm diameter), with or without 2,000 MW (molecular weight) polyethylene glycol (PEG), were injected intravenously into mice (5.55 MBq/25 pmol QD) and studied using well counting or by serial microPET and region-of-interest analysis. RESULTS: Both methods show rapid uptake by the liver (27.4-38.9 %ID/g) (%ID/g is percentage injected dose per gram tissue) and spleen (8.0-12.4 %ID/g). Size has no influence on biodistribution within the range tested here. Pegylated QD have slightly slower uptake into liver and spleen (6 vs. 2 min) and show additional low-level bone uptake (6.5-6.9 %ID/g). No evidence of clearance from these organs was observed. CONCLUSION: Rapid reticuloendothelial system clearance of QD will require modification of QD for optimal utility in imaging living subjects. Formal quantitative biodistribution/imaging studies will be helpful in studying many types of nanoparticles, including quantum dots.
Authors: P Laverman; M G Carstens; O C Boerman; E T Dams; W J Oyen; N van Rooijen; F H Corstens; G Storm Journal: J Pharmacol Exp Ther Date: 2001-08 Impact factor: 4.030
Authors: C Allen; N Dos Santos; R Gallagher; G N C Chiu; Y Shu; W M Li; S A Johnstone; A S Janoff; L D Mayer; M S Webb; M B Bally Journal: Biosci Rep Date: 2002-04 Impact factor: 3.840
Authors: P Laverman; A H Brouwers; E T Dams; W J Oyen; G Storm; N van Rooijen; F H Corstens; O C Boerman Journal: J Pharmacol Exp Ther Date: 2000-06 Impact factor: 4.030
Authors: Maria E Akerman; Warren C W Chan; Pirjo Laakkonen; Sangeeta N Bhatia; Erkki Ruoslahti Journal: Proc Natl Acad Sci U S A Date: 2002-09-16 Impact factor: 11.205
Authors: Christof Knoess; Stefan Siegel; Anne Smith; Danny Newport; Norbert Richerzhagen; Alexandra Winkeler; Andreas Jacobs; Rhonda N Goble; Rudolf Graf; Klaus Wienhard; Wolf-Dieter Heiss Journal: Eur J Nucl Med Mol Imaging Date: 2003-01-21 Impact factor: 9.236
Authors: Ted C Chu; Felice Shieh; Laura A Lavery; Matthew Levy; Rebecca Richards-Kortum; Brian A Korgel; Andrew D Ellington Journal: Biosens Bioelectron Date: 2006-02-21 Impact factor: 10.618
Authors: Min Zhou; Yunyun Chen; Makoto Adachi; Xiaoxia Wen; Bill Erwin; Osama Mawlawi; Stephen Y Lai; Chun Li Journal: Biomaterials Date: 2015-04-24 Impact factor: 12.479
Authors: Bryan Ronain Smith; Zhen Cheng; Abhijit De; Ai Leen Koh; Robert Sinclair; Sanjiv Sam Gambhir Journal: Nano Lett Date: 2008-04-04 Impact factor: 11.189
Authors: James A J Fitzpatrick; Susan K Andreko; Lauren A Ernst; Alan S Waggoner; Byron Ballou; Marcel P Bruchez Journal: Nano Lett Date: 2009-07 Impact factor: 11.189